Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.
about
Allosteric regulation of Csx1, a type IIIB-associated CARF domain ribonuclease by RNAs carrying a tetraadenylate tail.How bacteria control the CRISPR-Cas arsenal.Incomplete prophage tolerance by type III-A CRISPR-Cas systems reduces the fitness of lysogenic hosts.The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit.Mobile Genetic Elements and Evolution of CRISPR-Cas Systems: All the Way There and Back.Nuclease integrated kinase super assemblies (NiKs) and their role in RNA processing.Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis.Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6.Intracellular signaling in CRISPR-Cas defense.Pathogen detection in the CRISPR-Cas era.Microbiology: The case of the mysterious messenger.Shooting the messenger: RNA-targetting CRISPR-Cas systems.Control of cyclic oligoadenylate synthesis in a type III CRISPR systemInterkingdom microbial consortia mechanisms to guide biotechnological applicationsA Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate bindingRing nucleases deactivate type III CRISPR ribonucleases by degrading cyclic oligoadenylate
P2860
Q41924586-5205848E-AF4A-4F7E-8930-955B938B12B7Q45982664-A8A269D3-2094-430C-AFB5-FC0D4642BED8Q47557983-EF05E970-BF8D-4B0C-9D6A-FDC6664689FBQ47594743-C31AF3FF-B9F1-439D-9CD6-87D62B3E9F7FQ47687116-86E7D9B2-10E2-43D3-8088-721506F9A7A1Q48322324-F1CF995D-0373-4074-B767-2B4B5D9E0C08Q49886472-CD3BAB2A-203E-4F9C-A1E6-8E59944269D4Q49959418-D5A0FAF5-231C-457E-9287-261BC328D797Q52428531-D8C82744-8C01-49C3-A8C7-28E8AC1CE241Q52431837-C478B0BA-4A84-4AE8-8E8A-AFCB0BBFF06CQ53796100-AA10BA5F-7B66-4E0D-B019-1E8E40F4C386Q55436015-E5C383A8-2606-49DB-878C-37231358864AQ56885795-468A1738-6CB4-41EE-8164-A0E8A9626082Q57165376-38C00625-D18D-419F-8E38-95259F20D479Q58708478-106ABA0B-05DF-4B1D-AC5E-3D7D8621EEA4Q59071079-BEF201E8-102A-40F3-A55A-D2B08E900110
P2860
Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.
@en
Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.
@nl
type
label
Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.
@en
Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.
@nl
prefLabel
Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.
@en
Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.
@nl
P2093
P2860
P50
P356
P1433
P1476
Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.
@en
P2093
Frank Schwede
Jakob T Rostøl
Jonathan Hall
Luciano A Marraffini
Ole Niewoehner
P2860
P2888
P304
P356
10.1038/NATURE23467
P407
P577
2017-07-19T00:00:00Z
P6179
1090717691